Published in JAMA on February 04, 2004
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet (2007) 3.13
Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am J Clin Nutr (2014) 2.81
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr (2009) 2.19
Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ (2006) 1.93
Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ (2010) 1.89
Chiropractic clinical practice guideline: evidence-based treatment of adult neck pain not due to whiplash. J Can Chiropr Assoc (2005) 1.85
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med (2009) 1.83
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75
Studying gene and gene-environment effects of uncommon and common variants on continuous traits: a marker-set approach using gene-trait similarity regression. Am J Hum Genet (2011) 1.71
Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm. J Cell Physiol (2011) 1.54
The homocysteine paradox. Arterioscler Thromb Vasc Biol (2008) 1.50
Plasma homocysteine and severe white matter disease. Neurol Sci (2007) 1.45
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37
Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products. CMAJ (2005) 1.34
Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol (2008) 1.33
Traffic-related particles are associated with elevated homocysteine: the VA normative aging study. Am J Respir Crit Care Med (2008) 1.27
Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis (2008) 1.26
The treatment of hyperhomocysteinemia. Annu Rev Med (2009) 1.23
Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol (2010) 1.23
Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open (2012) 1.20
Limitations of observational evidence: implications for evidence-based dietary recommendations. Adv Nutr (2014) 1.19
Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res (2012) 1.18
Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17
Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol (2008) 1.17
Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. Pharmacogenet Genomics (2008) 1.12
Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol (2011) 1.11
Vitamin B12 in health and disease. Nutrients (2010) 1.07
Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. J Clin Psychopharmacol (2012) 1.06
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis (2009) 1.06
Quo vadis: whither homocysteine research? Cardiovasc Toxicol (2009) 1.04
The polypill and cardiovascular disease. BMJ (2005) 1.04
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis (2008) 1.03
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. JAMA Psychiatry (2013) 1.02
Nutrition and aging: assessment and treatment of compromised nutritional status in frail elderly patients. Clin Interv Aging (2006) 0.98
Homocysteine lowering and cardiovascular disease risk: lost in translation. Can J Cardiol (2007) 0.98
Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis (2010) 0.98
Parkinson disease and comorbid cerebrovascular disease. Nat Rev Neurol (2009) 0.97
Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes. Cardiovasc Diabetol (2014) 0.97
A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr (2008) 0.96
Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans. PLoS Med (2005) 0.95
Effect of L-methionine on hot flashes in postmenopausal women: a randomized controlled trial. Menopause (2009) 0.95
Relationship between non-specific prescription pill adherence and ischemic stroke outcomes. Cerebrovasc Dis (2009) 0.95
Effects of L-isoleucine and L-valine on hot flushes and serum homocysteine: a randomized controlled trial. Obstet Gynecol (2008) 0.94
Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk. Neurology (2011) 0.94
Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J (2009) 0.94
Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat (2010) 0.94
Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke. PLoS Genet (2014) 0.93
Association between vitamin B12-containing supplement consumption and prevalence of biochemically defined B12 deficiency in adults in NHANES III (third national health and nutrition examination survey). Public Health Nutr (2009) 0.92
Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92
Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality. Stroke (2015) 0.91
Defects in homocysteine metabolism: diversity among hyperhomocyst(e)inemias. Clin Chem Lab Med (2007) 0.91
Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res (2009) 0.91
Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia. Acta Pharmacol Sin (2010) 0.91
Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors. Med Sci Monit (2013) 0.91
The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc Disord (2008) 0.90
Hearing impairment risk and interaction of folate metabolism related gene polymorphisms in an aging study. BMC Med Genet (2011) 0.89
Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. Nephrol Dial Transplant (2009) 0.89
Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia. Schizophr Bull (2014) 0.89
Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS One (2011) 0.89
MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. Am J Clin Nutr (2010) 0.88
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial. Neurology (2009) 0.88
Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial. Am J Epidemiol (2010) 0.87
Plasma total cysteine and total homocysteine and risk of myocardial infarction in women: a prospective study. Am Heart J (2010) 0.87
Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease. World J Gastroenterol (2009) 0.87
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Vasc Health Risk Manag (2007) 0.87
Homocysteine stimulates antioxidant response element-mediated expression of glutamate-cysteine ligase in mouse macrophages. Atherosclerosis (2008) 0.87
Effect of folic acid and betaine supplementation on flow-mediated dilation: a randomized, controlled study in healthy volunteers. PLoS Clin Trials (2006) 0.86
Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. J Neurol (2005) 0.86
Optimal combination secondary prevention drug treatment and stroke outcomes. Neurology (2014) 0.86
Revised D-A-CH intake recommendations for folate: how much is needed? Eur J Clin Nutr (2014) 0.85
Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial. Atherosclerosis (2007) 0.85
Stroke management. Ann Indian Acad Neurol (2011) 0.84
Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep (2014) 0.84
Acute myocardial infarction and pulmonary embolism in a young man with pernicious anemia-induced severe hyperhomocysteinemia. Thromb J (2009) 0.84
Homocysteine affects cardiomyocyte viability: concentration-dependent effects on reversible flip-flop, apoptosis and necrosis. Apoptosis (2007) 0.84
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack. Am J Med (2015) 0.84
Novel insights on interactions between folate and lipid metabolism. Biofactors (2013) 0.84
Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke (2013) 0.83
Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology. Nutrients (2013) 0.83
Vegan diet, subnormal vitamin B-12 status and cardiovascular health. Nutrients (2014) 0.83
Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors. J Neural Transm (Vienna) (2007) 0.82
Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism. Genes Nutr (2014) 0.82
The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism. Antioxid Redox Signal (2007) 0.82
Glycated hemoglobin independently predicts stroke recurrence within one year after acute first-ever non-cardioembolic strokes onset in A Chinese cohort study. PLoS One (2013) 0.82
Hyperhomocysteinemia and mortality after coronary artery bypass grafting. PLoS One (2006) 0.81
Dietary supplements and disease prevention - a global overview. Nat Rev Endocrinol (2016) 0.81
Genetic linkage of serum homocysteine in Dominican families: the Family Study of Stroke Risk and Carotid Atherosclerosis. Stroke (2010) 0.81
Factors associated with the steep increase in late-midlife stroke occurrence among US men. J Stroke Cerebrovasc Dis (2008) 0.81
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can J Cardiol (2006) 0.81
Animal models of ischemic stroke. Part one: modeling risk factors. Open Neurol J (2010) 0.81
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol (2008) 4.83
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78
Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.61
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med (2006) 4.23
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA (2010) 4.05
Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study. Arch Intern Med (2007) 4.05
Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care (2005) 3.96
Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol (2007) 3.48
Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med (2005) 3.00
Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med (2010) 2.95
Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail (2012) 2.88
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol (2008) 2.68
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke (2007) 2.63
Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000. Am J Epidemiol (2004) 2.59
A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57
Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med (2013) 2.55
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol (2007) 2.53
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst (2009) 2.53
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics (2010) 2.40
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst (2010) 2.35
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke (2006) 2.33
Using the whole cohort in the analysis of case-cohort data. Am J Epidemiol (2009) 2.27
Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation (2012) 2.20
A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol (2011) 2.19
Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension (2003) 2.12
The contribution of major risk factors and job strain to occupational class differences in coronary heart disease incidence: the MONICA Brianza and PAMELA population-based cohorts. Occup Environ Med (2010) 2.11
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS One (2008) 2.09
Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem (2009) 2.03
Improved Horvitz-Thompson Estimation of Model Parameters from Two-phase Stratified Samples: Applications in Epidemiology. Stat Biosci (2009) 2.01
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke (2013) 1.89
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol (2005) 1.88
Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke (2011) 1.86
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A (2009) 1.81
Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality. Prev Med (2009) 1.81
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke (2011) 1.80
Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail (2009) 1.76
Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke (2006) 1.75
Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997. Arch Intern Med (2002) 1.72
Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg (2004) 1.71
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke (2010) 1.69
Evidence-based criteria in the nutritional context. Nutr Rev (2010) 1.68
Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke (2011) 1.63
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J (2010) 1.63
Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care (2005) 1.62
Risk factors for mortality in the nurses' health study: a competing risks analysis. Am J Epidemiol (2010) 1.61
Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol (2012) 1.60
Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke (2003) 1.58
Motor vehicle accidents: the most common cause of traumatic vertebrobasilar ischemia. Can J Neurol Sci (2003) 1.56
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Geometry of the carotid bifurcation predicts its exposure to disturbed flow. Stroke (2008) 1.54
Reduced medication access: a marker for vulnerability in US stroke survivors. Stroke (2007) 1.53
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol (2010) 1.51
The "heart disease and stroke statistics--2013 update" and the need for a national cardiovascular surveillance system. Circulation (2012) 1.50
Moderate waist circumference and hypertension prevalence: the REGARDS Study. Am J Hypertens (2011) 1.50
Influence of noninvasive cardiovascular imaging in primary prevention: systematic review and meta-analysis of randomized trials. Arch Intern Med (2011) 1.50
Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail (2012) 1.50
Imputation of incident events in longitudinal cohort studies. Am J Epidemiol (2011) 1.48
Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke (2010) 1.48
Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care (2003) 1.48
The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int (2003) 1.48
Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord (2007) 1.47
Consumption of fish products across the lifespan and prostate cancer risk. PLoS One (2013) 1.46
Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors. Diabetes Care (2005) 1.46
The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001. BMC Cardiovasc Disord (2007) 1.45
MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study. Atherosclerosis (2009) 1.45
Effect of hyperhomocysteinemia on protein C activation and activity. Blood (2002) 1.45
Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clin Trials (2010) 1.44
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One (2011) 1.41
Diabetes, intracranial stenosis and microemboli in asymptomatic carotid stenosis. Can J Neurol Sci (2013) 1.41
Repeatability of heart rate variability measures. J Electrocardiol (2004) 1.40
Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med (2009) 1.40
Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI. Magn Reson Med (2002) 1.38
Regional differences in African Americans' high risk for stroke: the remarkable burden of stroke for Southern African Americans. Ann Epidemiol (2007) 1.36
Caregiving strain and all-cause mortality: evidence from the REGARDS study. J Gerontol B Psychol Sci Soc Sci (2012) 1.35
Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products. CMAJ (2005) 1.34